Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 99

1.

A Stromal Immune Module Correlated with the Response to Neoadjuvant Chemotherapy, Prognosis and Lymphocyte Infiltration in HER2-Positive Breast Carcinoma Is Inversely Correlated with Hormonal Pathways.

Hamy AS, Bonsang-Kitzis H, Lae M, Moarii M, Sadacca B, Pinheiro A, Galliot M, Abecassis J, Laurent C, Reyal F.

PLoS One. 2016 Dec 22;11(12):e0167397. doi: 10.1371/journal.pone.0167397.

2.

Caveolin-1-negative head and neck squamous cell carcinoma primary tumors display increased epithelial to mesenchymal transition and prometastatic properties.

Jung AC, Ray AM, Ramolu L, Macabre C, Simon F, Noulet F, Blandin AF, Renner G, Lehmann M, Choulier L, Kessler H, Abecassis J, Dontenwill M, Martin S.

Oncotarget. 2015 Dec 8;6(39):41884-901. doi: 10.18632/oncotarget.6099.

3.

Human Papillomavirus-related tumours of the oropharynx display a lower tumour hypoxia signature.

Hanns E, Job S, Coliat P, Wasylyk C, Ramolu L, Pencreach E, Suarez-Carmona M, Herfs M, Ledrappier S, Macabre C, Abecassis J, Wasylyk B, Jung AC.

Oral Oncol. 2015 Sep;51(9):848-56. doi: 10.1016/j.oraloncology.2015.06.003.

PMID:
26121938
4.

From ERα66 to ERα36: a generic method for validating a prognosis marker of breast tumor progression.

Chamard-Jovenin C, Jung AC, Chesnel A, Abecassis J, Flament S, Ledrappier S, Macabre C, Boukhobza T, Dumond H.

BMC Syst Biol. 2015 Jun 17;9:28. doi: 10.1186/s12918-015-0178-7.

5.

Use of preoperative FLAIR MRI and ependymal proximity of tumor enhancement as surrogate markers of brain tumor origin.

Smith TR, Hulou MM, Abecassis J, Das S, Chandler JP.

J Clin Neurosci. 2015 Sep;22(9):1397-402. doi: 10.1016/j.jocn.2015.02.029.

PMID:
26055954
6.

The 3D organization of chromatin explains evolutionary fragile genomic regions.

Berthelot C, Muffato M, Abecassis J, Roest Crollius H.

Cell Rep. 2015 Mar 24;10(11):1913-24.

7.

Relationships between wheat grain physical characteristics studied through near-isogenic lines with distinct puroindoline-b allele.

Oury FX, Lasme P, Michelet C, Rousset M, Abecassis J, Lullien-Pellerin V.

Theor Appl Genet. 2015 May;128(5):913-29. doi: 10.1007/s00122-015-2479-z.

PMID:
25716819
8.

Stimulation of breast cancer cell lines by post-surgical drainage fluids.

Ramolu L, Christ D, Abecassis J, Rodier JF.

Anticancer Res. 2014 Jul;34(7):3489-92.

PMID:
24982358
9.

[Transapical aortic valve replacement: A 5-years experience].

Nolasco T, Campante Teles R, Brito J, Abecassis M, Almeida M, Abecassis J, Ribeiras R, Mesquita Gabriel H, Neves J.

Rev Port Cir Cardiotorac Vasc. 2014 Apr-Jun;21(2):93-97. Portuguese.

PMID:
27855245
10.

Identification of clinically relevant HPV-related HNSCC: in p16 should we trust?

Wasylyk B, Abecassis J, Jung AC.

Oral Oncol. 2013 Oct;49(10):e33-7. doi: 10.1016/j.oraloncology.2013.07.014. Review. No abstract available.

PMID:
23962789
11.

DDB2: a novel regulator of NF-κB and breast tumor invasion.

Ennen M, Klotz R, Touche N, Pinel S, Barbieux C, Besancenot V, Brunner E, Thiebaut D, Jung AC, Ledrappier S, Domenjoud L, Abecassis J, Plénat F, Grandemange S, Becuwe P.

Cancer Res. 2013 Aug 15;73(16):5040-52. doi: 10.1158/0008-5472.CAN-12-3655.

12.

A poor prognosis subtype of HNSCC is consistently observed across methylome, transcriptome, and miRNome analysis.

Jung AC, Job S, Ledrappier S, Macabre C, Abecassis J, de Reyniès A, Wasylyk B.

Clin Cancer Res. 2013 Aug 1;19(15):4174-84. doi: 10.1158/1078-0432.CCR-12-3690.

13.

The NEDD8 conjugation pathway regulates p53 transcriptional activity and head and neck cancer cell sensitivity to ionizing radiation.

Guihard S, Ramolu L, Macabre C, Wasylyk B, Noël G, Abecassis J, Jung AC.

Int J Oncol. 2012 Oct;41(4):1531-40. doi: 10.3892/ijo.2012.1584.

PMID:
22895816
14.

CD8-alpha T-cell infiltration in human papillomavirus-related oropharyngeal carcinoma correlates with improved patient prognosis.

Jung AC, Guihard S, Krugell S, Ledrappier S, Brochot A, Dalstein V, Job S, de Reynies A, Noël G, Wasylyk B, Clavel C, Abecassis J.

Int J Cancer. 2013 Jan 15;132(2):E26-36. doi: 10.1002/ijc.27776.

15.

BRCA1 R1699Q variant displaying ambiguous functional abrogation confers intermediate breast and ovarian cancer risk.

Spurdle AB, Whiley PJ, Thompson B, Feng B, Healey S, Brown MA, Pettigrew C; kConFab., Van Asperen CJ, Ausems MG, Kattentidt-Mouravieva AA, van den Ouweland AM; Dutch Belgium UV Consortium., Lindblom A, Pigg MH, Schmutzler RK, Engel C, Meindl A; German Consortium of Hereditary Breast and Ovarian Cancer., Caputo S, Sinilnikova OM, Lidereau R; French COVAR group collaborators., Couch FJ, Guidugli L, Hansen Tv, Thomassen M, Eccles DM, Tucker K, Benitez J, Domchek SM, Toland AE, Van Rensburg EJ, Wappenschmidt B, Borg Å, Vreeswijk MP, Goldgar DE; ENIGMA Consortium..

J Med Genet. 2012 Aug;49(8):525-32.

16.

Description and analysis of genetic variants in French hereditary breast and ovarian cancer families recorded in the UMD-BRCA1/BRCA2 databases.

Caputo S, Benboudjema L, Sinilnikova O, Rouleau E, Béroud C, Lidereau R; French BRCA GGC Consortium..

Nucleic Acids Res. 2012 Jan;40(Database issue):D992-1002. doi: 10.1093/nar/gkr1160.

17.

An entire exon 3 germ-line rearrangement in the BRCA2 gene: pathogenic relevance of exon 3 deletion in breast cancer predisposition.

Muller D, Rouleau E, Schultz I, Caputo S, Lefol C, Bièche I, Caron O, Noguès C, Limacher JM, Demange L, Lidereau R, Fricker JP, Abecassis J.

BMC Med Genet. 2011 Sep 22;12:121. doi: 10.1186/1471-2350-12-121.

18.

ANO1 amplification and expression in HNSCC with a high propensity for future distant metastasis and its functions in HNSCC cell lines.

Ayoub C, Wasylyk C, Li Y, Thomas E, Marisa L, Robé A, Roux M, Abecassis J, de Reyniès A, Wasylyk B.

Br J Cancer. 2010 Aug 24;103(5):715-26. doi: 10.1038/sj.bjc.6605823.

19.

Tubulin tyrosine ligase like 12 links to prostate cancer through tubulin posttranslational modification and chromosome ploidy.

Wasylyk C, Zambrano A, Zhao C, Brants J, Abecassis J, Schalken JA, Rogatsch H, Schaefer G, Pycha A, Klocker H, Wasylyk B.

Int J Cancer. 2010 Dec 1;127(11):2542-53. doi: 10.1002/ijc.25261.

20.

Biological and clinical relevance of transcriptionally active human papillomavirus (HPV) infection in oropharynx squamous cell carcinoma.

Jung AC, Briolat J, Millon R, de Reyniès A, Rickman D, Thomas E, Abecassis J, Clavel C, Wasylyk B.

Int J Cancer. 2010 Apr 15;126(8):1882-94. doi: 10.1002/ijc.24911.

Items per page

Supplemental Content

Loading ...
Support Center